WASHINGTON: The US Food and Drug Administration (FDA) on Wednesday (Aug 27) authorized up to date COVID-19 vaccines for everybody aged 65 and over however narrowed entry for youthful individuals to these with well being dangers, a shift from earlier years when most People had been eligible.
The three authorized photographs are made by Pfizer and German companion BioNTech, Moderna, and Novavax with Sanofi.
“Right this moment’s choice doesn’t have an effect on entry to those vaccines. These vaccines stay accessible to those that select them in session with their healthcare supplier,” a US Division of Well being and Human Providers (HHS) spokesperson stated.
CHILDREN’S ACCESS CURTAILED
Pfizer stated the emergency use authorisation for its COVID vaccine for youngsters beneath 5 was rescinded, doubtlessly limiting entry for paediatric teams.
Moderna stated its up to date Spikevax shot was authorized for individuals aged six months and older with at the least one underlying situation, and can be accessible within the coming days.
Pfizer and BioNTech’s up to date Comirnaty was cleared for individuals aged 5 to 64 with high-risk situations. Novavax’s vaccine was authorized beneath the identical standards for these aged 12 to 64.
All three vaccines stay accessible to individuals 65 and older with out restrictions.
